This session will provide attendees with a thorough understanding of trends in adoption in the U.S. of guideline-recommended diabetic kidney disease treatments, practical tips about how to safely prescribe SGLT2is, GLP1-RAs, nsMRAs, and interpret continuous glucose monitoring (CGM). In addition, attendees will learn about the increasingly important role that clinical decision support may play in improving adherence to guideline-directed medical therapy and opportunities to apply to diabetic kidney disease.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
- Paid · fee on provider site
-
ReleasedDec 11, 2025
-
Last day to claim creditDec 13, 2027 1 year left
-
National Kidney Foundation Optimizing CKM Care with Guideline-Directed and Aldosterone-Targeted Therapies using a Team Approach
-
National Kidney Foundation Navigating the Changing Landscape: 2025 Kidney Care Policy and Regulatory Update
-
National Kidney Foundation Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Focus: Guiding Practice Through the Latest KDIGO Guidelines
